Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ICLR – ICON Public Limited Company

Float Short %

3.68

Margin Of Safety %

21

Put/Call OI Ratio

0.73

EPS Next Q Diff

0.41

EPS Last/This Y

3.48

EPS This/Next Y

0.42

Price

186.76

Target Price

205.38

Analyst Recom

1.84

Performance Q

9.46

Relative Volume

0.71

Beta

1.25

Ticker: ICLR




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-13ICLR163.530.400.527643
2025-11-14ICLR162.20.381.627552
2025-11-17ICLR156.520.390.057693
2025-11-18ICLR1610.392.827658
2025-11-19ICLR158.750.390.829447
2025-11-20ICLR1590.384.249703
2025-11-21ICLR164.370.372.179765
2025-11-24ICLR164.60.400.734496
2025-11-25ICLR174.540.460.025022
2025-11-26ICLR183.680.510.034712
2025-12-01ICLR179.780.5614.644494
2025-12-02ICLR183.260.451.364192
2025-12-03ICLR187.770.490.064374
2025-12-04ICLR185.710.466.624636
2025-12-05ICLR186.870.680.005710
2025-12-08ICLR182.10.680.935716
2025-12-09ICLR181.270.681.605718
2025-12-10ICLR185.770.680.195724
2025-12-11ICLR186.530.671.955742
2025-12-12ICLR186.570.732.086195
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-13ICLR163.48-3.0442.513.08
2025-11-14ICLR162.17-3.0433.913.08
2025-11-17ICLR156.66-3.0408.713.08
2025-11-18ICLR161.01-3.0507.213.08
2025-11-19ICLR158.81-3.0463.913.08
2025-11-20ICLR158.35-3.0475.313.08
2025-11-21ICLR164.20-3.0480.313.08
2025-11-24ICLR164.45-3.0441.713.08
2025-11-25ICLR174.53-3.0501.013.08
2025-11-26ICLR183.68-3.0493.713.08
2025-12-01ICLR179.71-3.0412.213.08
2025-12-02ICLR183.14-3.0460.013.08
2025-12-03ICLR187.78-3.0466.613.08
2025-12-04ICLR185.94-3.0431.213.08
2025-12-05ICLR185.87-3.1441.713.08
2025-12-08ICLR182.10-3.1- 13.08
2025-12-09ICLR181.29-3.1436.613.08
2025-12-10ICLR181.29-3.1466.413.08
2025-12-11ICLR189.93-3.1463.613.08
2025-12-12ICLR186.76-3.1424.213.08
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-13ICLR0.0012.562.44
2025-11-14ICLR0.0012.562.44
2025-11-17ICLR0.0015.552.45
2025-11-18ICLR0.0015.552.44
2025-11-19ICLR0.0015.552.44
2025-11-20ICLR0.0015.552.44
2025-11-21ICLR0.0015.552.45
2025-11-24ICLR0.00-2.862.45
2025-11-25ICLR0.00-2.862.45
2025-11-26ICLR0.00-2.862.46
2025-12-01ICLR0.00-2.802.51
2025-12-02ICLR0.00-2.802.51
2025-12-03ICLR0.00-2.802.51
2025-12-04ICLR0.00-2.802.51
2025-12-05ICLR0.00-2.802.51
2025-12-08ICLR0.00-2.862.51
2025-12-09ICLR0.00-2.862.51
2025-12-10ICLR0.00-2.863.68
2025-12-11ICLR0.00-2.863.68
2025-12-12ICLR0.00-2.863.68
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ICLR" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

2.83

Avg. EPS Est. Current Quarter

3.32

Avg. EPS Est. Next Quarter

3.24

Insider Transactions

Institutional Transactions

-2.86

Beta

1.25

Average Sales Estimate Current Quarter

2012

Average Sales Estimate Next Quarter

2005

Fair Value

225.91

Quality Score

69

Growth Score

78

Sentiment Score

65

Actual DrawDown %

46.3

Max Drawdown 5-Year %

-63.4

Target Price

205.38

P/E

25.22

Forward P/E

13.91

PEG

7.52

P/S

1.76

P/B

1.53

P/Free Cash Flow

14.67

EPS

7.4

Average EPS Est. Cur. Y​

13.08

EPS Next Y. (Est.)

13.5

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

7.4

Relative Volume

0.71

Return on Equity vs Sector %

-20.5

Return on Equity vs Industry %

-4.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

424.2
[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ICLR” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ICLR” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ICLR” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ICLR” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ICLR” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ICLR” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ICLR” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
ICON plc
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 39800
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
stock quote shares ICLR – ICON Public Limited Company Stock Price stock today
news today ICLR – ICON Public Limited Company stock forecast ,stock prediction 2023 2024 2025
marketwatch ICLR – ICON Public Limited Company yahoo finance google finance
stock history ICLR – ICON Public Limited Company invest stock market
stock prices ICLR premarket after hours
ticker ICLR fair value insiders trading